Actuate Therapeutics
ACTU
10 hedge funds and large institutions have $2.85M invested in Actuate Therapeutics in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.96% more ownership
Funds ownership: 0% → 1.96% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
+$1.1M |
| 2 |
LCAM
Long Corridor Asset Management
Hong Kong
|
+$990K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$279K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$221K |
| 5 |
NU
Northwestern University
Evanston,
Illinois
|
+$220K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $1.04M | +$1.1M | +139,511 | New |
|
|
LCAM
2
Long Corridor Asset Management
Hong Kong
| $931K | +$990K | +125,000 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $263K | +$279K | +35,300 | New |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $208K | +$221K | +27,893 | New |
|
|
NU
5
Northwestern University
Evanston,
Illinois
| $207K | +$220K | +27,778 | New |
|
|
KLCM
6
KG&L Capital Management
Saint Francisville,
Louisiana
| $89.4K | +$95K | +12,000 | New |
|
7
Citigroup
New York
| $81.7K | +$86.9K | +10,973 | New |
|
8
Wells Fargo
San Francisco,
California
| $25.3K | +$26.9K | +3,392 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2.21K | +$2.35K | +297 | New |
|
10
Bank of America
Charlotte,
North Carolina
| $171 | +$182 | +23 | New |
|
ACTU Hedge Fund Activity: Q3 2024 in Review
10 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Actuate Therapeutics (ACTU) for Q3 2024, worth a combined $2.85M.
Buyers outnumbered sellers: 10 funds opened new ACTU positions and 0 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was AWM Investment Company, opening a new position worth an estimated $1.1M.
- 10 institutional investors held Actuate Therapeutics (ACTU) as of Q3 2024, up from 0 in Q2 2024.
- Funds reported $2.85M of Actuate Therapeutics stock for Q3 2024.
- 10 funds opened new Actuate Therapeutics positions in Q3 2024 and 0 closed out, a net change of +10 holders.
- The largest Actuate Therapeutics buyer in Q3 2024 was AWM Investment Company, an estimated $1.1M added.
Based on aggregated 13F filings for Q3 2024.